ALNYLAM PHARMACEUTICALS, INC. financial data

Symbol
ALNY on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 277% % -7.4%
Quick Ratio 5.7% % -31%
Debt-to-equity 2579% %
Return On Equity 26% % -92%
Return On Assets 0.98% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 132,113,818 shares 2.4%
Common Stock, Shares, Outstanding 131,791,000 shares 2.3%
Entity Public Float $30,990,000,000 USD 31%
Common Stock, Value, Issued $1,318,000 USD 2.2%
Weighted Average Number of Shares Outstanding, Basic 131,447,000 shares 2.2%
Weighted Average Number of Shares Outstanding, Diluted 137,348,000 shares 6.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $3,210,070,000 USD 53%
Research and Development Expense $1,247,726,000 USD 14%
Costs and Expenses $2,945,369,000 USD 29%
Operating Income (Loss) $264,701,000 USD
Nonoperating Income (Expense) $296,644,000 USD -123%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $31,943,000 USD 90%
Income Tax Expense (Benefit) $75,508,000 USD -777%
Net Income (Loss) Attributable to Parent $43,565,000 USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,490,249,000 USD 35%
Accounts Receivable, after Allowance for Credit Loss, Current $964,768,000 USD 173%
Inventory, Net $75,383,000 USD -0.8%
Assets, Current $3,952,811,000 USD 18%
Deferred Income Tax Assets, Net $98,558,000 USD
Property, Plant and Equipment, Net $501,754,000 USD -1%
Operating Lease, Right-of-Use Asset $191,390,000 USD -2.6%
Other Assets, Noncurrent $55,835,000 USD -28%
Assets $4,851,662,000 USD 15%
Accounts Payable, Current $117,591,000 USD 66%
Employee-related Liabilities, Current $214,399,000 USD 75%
Accrued Liabilities, Current $1,153,648,000 USD 22%
Contract with Customer, Liability, Current $2,541,000 USD -96%
Liabilities, Current $1,555,477,000 USD 27%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $223,421,000 USD -5.3%
Other Liabilities, Noncurrent $9,769,000 USD -97%
Liabilities $4,617,768,000 USD 11%
Accumulated Other Comprehensive Income (Loss), Net of Tax $21,775,000 USD 12%
Retained Earnings (Accumulated Deficit) $7,160,420,000 USD 0.6%
Stockholders' Equity Attributable to Parent $233,894,000 USD 623%
Liabilities and Equity $4,851,662,000 USD 15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $118,314,000 USD -45%
Net Cash Provided by (Used in) Financing Activities $44,084,000 USD 52%
Net Cash Provided by (Used in) Investing Activities $113,769,000 USD
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 131,791,000 shares 2.3%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $53,597,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,492,802,000 USD 35%
Interest Paid, Excluding Capitalized Interest, Operating Activities $66,933,000 USD 116%
Deferred Tax Assets, Valuation Allowance $2,788,933,000 USD -1%
Deferred Tax Assets, Gross $2,967,630,000 USD 2.4%
Operating Lease, Liability $271,427,000 USD -4.6%
Payments to Acquire Property, Plant, and Equipment $8,970,000 USD -31%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $46,616,000 USD
Lessee, Operating Lease, Liability, to be Paid $384,489,000 USD -8%
Property, Plant and Equipment, Gross $773,148,000 USD 3.2%
Operating Lease, Liability, Current $44,755,000 USD 6.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $46,180,000 USD -0.41%
Lessee, Operating Lease, Liability, to be Paid, Year One $43,384,000 USD -0.47%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) $9,639,000 USD 2023%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $113,062,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year Three $41,590,000 USD 2.3%
Deferred Tax Assets, Operating Loss Carryforwards $882,569,000 USD 9.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $53,100,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $40,525,000 USD 3.9%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $368,248,000 USD 66%
Interest Expense $127,519,000 USD -11%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%